Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China · Delayed Price · Currency is CNY 39.38
-0.67 (-1.67%)
Aug 14, 2026, 3:00 PM CST
SHA:600211 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,885 | 2,982 | 2,807 | 3,134 | 2,555 | 2,139 |
Revenue Growth | 1.50% | 6.23% | -10.45% | 22.69% | 19.45% | 55.75% |
Gross Profit Gross Profit Growth | 2,694 | 2,810 | 2,645 | 2,976 | 2,350 | 1,913 |
Operating Income Operating Income Growth | 981.1 | 924.66 | 893.44 | 1,039 | 688.27 | 572.75 |
Net Income Net Income Growth | 978.57 | 937.93 | 1,051 | 800.91 | 369.84 | 208.94 |
Earnings Per Share EPS Growth | 3.06 | 2.91 | 3.26 | 2.48 | 1.15 | 0.65 |
EPS Growth | -1.11% | -10.74% | 31.45% | 116.37% | 77.38% | -50.29% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Offset of Business Segment Offset of Business Segment Growth | -1,840 |
Medicine Manufacturing Medicine Manufacturing Growth | 1,991 |
Other Other Growth | 2.64 |
Pharmaceutical Business Pharmaceutical Business Growth | 2,824 |
Total Total Growth | 2,978 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,741 | 3,450 | 2,625 | 2,375 | 1,932 | 1,302 |
Total Debt Total Debt Growth | 1,130 | 841.34 | 273.39 | 501.99 | 488.25 | 538.65 |
Net Cash (Debt) Net Cash Growth | 2,610 | 2,609 | 2,351 | 1,873 | 1,444 | 763.63 |
Net Cash Growth | 11.85% | 10.95% | 25.54% | 29.71% | 89.11% | -1.22% |
Net Cash Per Share Net Cash Per Share Growth | 8.15 | 8.09 | 7.29 | 5.80 | 4.48 | 2.36 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 883.69 | 1,005 | 994.79 | 1,063 | 837.38 | 366.53 |
Capital Expenditures CapEx Growth | -13.59 | -15.96 | -37.6 | -21.69 | -101.96 | -425.58 |
Free Cash Flow Free Cash Flow Growth | 870.11 | 988.79 | 957.19 | 1,042 | 735.41 | -59.05 |
Free Cash Flow Growth | -9.71% | 3.30% | -8.12% | 41.65% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 93.38% | 94.23% | 94.23% | 94.94% | 91.98% | 89.44% |
Operating Margin | 34.00% | 31.01% | 31.83% | 33.14% | 26.94% | 26.78% |
Pretax Margin | 36.05% | 34.90% | 41.05% | 28.66% | 18.14% | 11.92% |
Profit Margin | 33.92% | 31.46% | 37.46% | 25.55% | 14.48% | 9.77% |
FCF Margin | 30.16% | 33.16% | 34.10% | 33.24% | 28.79% | -2.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.757 | 1.757 | 1.957 | 1.492 | 0.574 | 0.260 |
Dividend Per Share Growth | -10.22% | -10.22% | 31.21% | 159.93% | 120.69% | -33.72% |
Dividend Yield | 4.46% | 4.22% | 5.67% | 4.44% | 2.40% | 0.75% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.89 | 14.62 | 11.33 | 15.11 | 24.08 | 62.13 |
Forward PE | - | 10.16 | 10.20 | 9.13 | 26.48 | 26.48 |
P/FCF Ratio | 14.41 | 13.87 | 12.44 | 11.62 | 12.11 | - |
PS Ratio | 4.34 | 4.60 | 4.24 | 3.86 | 3.49 | 6.07 |